Angiotensin-II receptors: New targets for antihypertensive therapy

Clinical Cardiology

Volumn 20, Issue 1, 1997, Pages 3-6

  Oliverio, Michael I ^a   Coffman, Thomas M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin II; angiotensinogen; AT1 receptor; AT1 receptor blocker; hypertension; losartan; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; CELL SURFACE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTERY CONSTRICTION; BLOOD PRESSURE REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; HYPERTENSION; PATHOGENESIS; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0031030268     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200103     Document Type: Review

References (19)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: Role of angiotensinogen. Cell I992;71:I69-180
2. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jeannette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the ansiotensinogen locus. Proc Natl Acad Sci USA 1995:92:2735-2739
3. Hubert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S: Chromosomal mapping of two genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature 1991;353:521-529
4. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES: Genetic mapping of a gene causing hypertension in the stroke prone spontaneously hypertensive rat. Cell 1991 ;67:213-224
5. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990;81:1161-1172
6. Guyton A: Abnormal renal function and autoregulation in essential hypertension. Hypertension 1991 ; 18(suppl III):49-53
7. Hall J: Control of sodium excretion by angiotensin II: Intrarenal mechanisms and blood pressure regulation. Am J Pliysiol 1986; 250:R960-R972
8. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pliannacol Rev 1993;45:205-251
9. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ: Expression cloning of type 2 angiotensin receptor reveals a unique class of seven-transmembrane domain receptors. J Biol Chem 1993;268(33):24539-24542
10. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T: Molecular cloning of a novel angiotensin II receptor isofonn involved in phosphotyrosine phosphatase inhibition. JBiolCliem 1993;268:24543-24546
11. Murphy TJ, Takcuchi K, Alexander RW: Molecular cloning of ATI angiotensin receptors. Am J Hypertens 1992;5:236S-242S
12. Case J-M, Shanmugam S, Sibony M, Corvol P: Tissue-specific expression of type I angiotensin II subtypes. An in situ hybridization study. Hypertension 1994;24:531-537
13. Burson JM, Aguilera G, Gross KVV, Sigmund CD: Differential expression of angiotensin receptor 1A and 1 Binmouse.AinJPIiysiol 1994;267:E260-E267
14. Llorens-Cortes C, Greenberg B, Huang H, Corvol P: Tissularexpression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994;24:538-548
15. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A receptor for angiotensin II. Proc Nail AcadSci USA 1995;92:3521-3525
16. Goldberg AI, Dunlay MC, Sweet CS: Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995;75:793-795
17. Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB: Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med 1995;755:405-411
18. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, Snavely DB, Sweet CS: A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995;25:1345-1350
19. Lacourcière Y, Brunner H, Irwin R, Karlberg BE, Ramsay LE, Snavely DB, Dobbins TW, Faison EP, Nelson EB, Losartan Cough Study Group: Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994; 12:1387-1393